Teodora Doherty

Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study

Naim Zaki, Li Chen, Rosanne Lane et al. · Neuropsychopharmacology · 2023 · 120 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program

Teodora Doherty, Ewa Wajs, Rama Melkote et al. · CNS Drugs · 2020 · 66 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression

Eva G. Katz, David Hough, Teodora Doherty et al. · Clinical Pharmacology & Therapeutics · 2020 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

David M. Kern, Carla M. Canuso, Ella Daly et al. · Brain and Behavior · 2023 · 34 citations · Full text

Medicine, Internal Medicine, Psychiatry +12

Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study

Naim Zaki, Li Chen, Rosanne Lane et al. · The International Journal of Neuropsychopharmacology · 2025 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17